Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001477932-24-006301
Filing Date
2024-10-09
Accepted
2024-10-09 13:38:17
Documents
120
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A avrw_10qa.htm   iXBRL 10-Q/A 1692306
2 CERTIFICATION avrw_ex311.htm EX-31.1 10452
3 CERTIFICATION avrw_ex312.htm EX-31.2 10784
4 CERTIFICATION avrw_ex321.htm EX-32.1 4206
5 CERTIFICATION avrw_ex322.htm EX-32.2 4249
  Complete submission text file 0001477932-24-006301.txt   9963053

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA curr-20210930.xsd EX-101.SCH 121822
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20210930_lab.xml EX-101.LAB 596909
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20210930_cal.xml EX-101.CAL 81697
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20210930_pre.xml EX-101.PRE 520785
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20210930_def.xml EX-101.DEF 315895
123 EXTRACTED XBRL INSTANCE DOCUMENT avrw_10qa_htm.xml XML 1811597
Mailing Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411
Business Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411 424-273-8675
Avenir Wellness Solutions, Inc. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-55908 | Film No.: 241362308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)